Fig. 3
From: Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer
Relationship between NUSAP1 expression and chemotherapy in patients with ovarian cancer. a–b Prognostic significance of NUSAP1 in patients with ovarian cancer treated with platinum-paclitaxel combination or platinum chemotherapy. c–h Prognostic significance of NUSAP1 in patients with serous ovarian cancer treated with platinum-paclitaxel combination or other monotherapies. i-k Prognostic significance of NUSAP1 in patients with high-grade serous ovarian cancer treated with platinum-paclitaxel combination or other monotherapies